The company witnesses strong growth across its India, Africa, and emerging markets businesses, while securing regulatory approval for the first AB-rated gVentolin in the U.S. market
The company reported a 108% rise in profit after tax, driven by strong growth in regulated markets, branded generics, and U.S. expansion initiatives
Global specialty pipeline accelerates growth
We are building an AI-native operating system for pharma sales and distribution
Bengaluru startup targets 100+ enterprise clients and global expansion as it aims to transform pharmaceutical sales, marketing, tenders, and distribution using AI agents
The six-part webinar series aims to enhance awareness, diagnosis, and management of autoimmune diseases
India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells
Mumbai event on June 24–25 will spotlight real-world impact of pharmacovigilance beyond AI adoption
The biosimilars business generated Rs. 10,431 crore in FY26 revenue, up 16% year-on-year
U.S. business drives strong growth as Lupin reports 57% rise in Q4 U.S. sales and 43% increase in gross profit
Subscribe To Our Newsletter & Stay Updated
